Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia
1.917
Zitationen
29
Autoren
2007
Jahr
Abstract
Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A. (ClinicalTrials.gov number, NCT00207597 [ClinicalTrials.gov].).
Ähnliche Arbeiten
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 · 3.832 Zit.
Hematological Problems in Pediatric Intensive Care
2013 · 3.514 Zit.
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 · 1.984 Zit.
Guidelines for the management of hemophilia
2012 · 1.910 Zit.
Hemostasis and Thrombosis: Basic Principles and Clinical Practice.
1988 · 1.857 Zit.
Autoren
- Marilyn J. Manco‐Johnson
- Thomas C. Abshire
- Amy D. Shapiro
- Brenda Riske
- Michele R. Hacker
- Ray F. Kilcoyne
- J. David Ingram
- M L Manco-Johnson
- Sharon Funk
- Linda Jacobson
- Leonard A. Valentino
- W. Keith Hoots
- George R. Buchanan
- Donna DiMichele
- Michael Recht
- Deborah Brown
- Cindy Leissinger
- Shirley Bleak
- Alan R. Cohen
- Prasad Mathew
- Alison Matsunaga
- Desiree Medeiros
- Diane J. Nugent
- Gregory A. Thomas
- Alexis A. Thompson
- Kevin McRedmond
- J. Michael Soucie
- Harlan Austin
- Bruce L. Evatt